Bowel cancer stage III chemotherapy six times is a certain therapeutic effect, and the five-year survival rate is ranging from 50% to 60%. Bowel cancer is a malignant tumor caused by a variety of factors, such as bad dietary habits, gene mutation, heredity, etc., with colon cancer and rectal cancer being more prevalent. The main treatments after diagnosis are surgical resection, chemotherapy, often combined with radiotherapy, targeted therapy and other therapies. The number of postoperative adjuvant chemotherapy for bowel cancer usually ranges from 6 to 8 times, and commonly used chemotherapeutic drugs include 5-fluorouracil, capecitabine, etc., and it should be noted that they should be used under the guidance of doctors. After six times of chemotherapy, patients with stage III bowel cancer can get a better prognosis, and the five-year survival rate is about 50% to 60%.